Bath and Body Works SPF Tahiti Isle
NDC 62670-6868, Avobenzone,Homosalate,Octisalate,Octocrylene, lotion, from Bath & Body Works, Inc..
- Product NDC
- 62670-6868
- Status
- Listed
- Labeler
- Bath & Body Works, Inc.
- Dosage form
- LOTION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62670-6868 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTOCRYLENE10 mg/100mg
- AVOBENZONE3 mg/100mg
- HOMOSALATE10 mg/100mg
- OCTISALATE5 mg/100mg
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62670-6868-0 | 62670686800 | 74 mg in 1 BOTTLE (62670-6868-0) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62670-6868 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62670-6868 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62670-6868. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.